Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

InSite Vision licenses novel TIGR modifier gene

Feb. 2, 2000

Alcon makes milestone payment to Pharmacyclics for Optrin

Feb. 1, 2000

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Jan. 19, 2000

Pharmacia & Upjohn seeks approval for combination glaucoma therapy

Jan. 11, 2000

Inspire's dry eye product enters phase II testing

Jan. 10, 2000

Allergan's therapy for allergic conjunctivitis approved for U.S. marketing

Dec. 27, 1999

Milestone reached by Xoma in collaboration with Allergan

Dec. 27, 1999

Allergan expands ophthalmic allergy product portfolio

Dec. 21, 1999

Swiss regulatory authorities grant Visudyne Therapy its first approval

Dec. 20, 1999

Pharmos seeks approval for Loterox in the U.K.

Dec. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...